BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22142239)

  • 1. A co-ordinated interaction between CTCF and ER in breast cancer cells.
    Ross-Innes CS; Brown GD; Carroll JS
    BMC Genomics; 2011 Dec; 12():593. PubMed ID: 22142239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTCF modulates Estrogen Receptor function through specific chromatin and nuclear matrix interactions.
    Fiorito E; Sharma Y; Gilfillan S; Wang S; Singh SK; Satheesh SV; Katika MR; Urbanucci A; Thiede B; Mills IG; Hurtado A
    Nucleic Acids Res; 2016 Dec; 44(22):10588-10602. PubMed ID: 27638884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCCTC-binding factor acts upstream of FOXA1 and demarcates the genomic response to estrogen.
    Zhang Y; Liang J; Li Y; Xuan C; Wang F; Wang D; Shi L; Zhang D; Shang Y
    J Biol Chem; 2010 Sep; 285(37):28604-13. PubMed ID: 20610384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXA1 is a key determinant of estrogen receptor function and endocrine response.
    Hurtado A; Holmes KA; Ross-Innes CS; Schmidt D; Carroll JS
    Nat Genet; 2011 Jan; 43(1):27-33. PubMed ID: 21151129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More on FOX News: FOXA1 on the horizon of estrogen receptor function and endocrine response.
    Fu X; Huang C; Schiff R
    Breast Cancer Res; 2011 Apr; 13(2):307. PubMed ID: 21575280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transducin-like enhancer protein 1 mediates estrogen receptor binding and transcriptional activity in breast cancer cells.
    Holmes KA; Hurtado A; Brown GD; Launchbury R; Ross-Innes CS; Hadfield J; Odom DT; Carroll JS
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2748-53. PubMed ID: 21536917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rearranged during transfection/papillary thyroid carcinoma tyrosine kinase is an estrogen-dependent gene required for the growth of estrogen receptor positive breast cancer cells.
    Wang C; Mayer JA; Mazumdar A; Brown PH
    Breast Cancer Res Treat; 2012 Jun; 133(2):487-500. PubMed ID: 21947652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer.
    Ross-Innes CS; Stark R; Teschendorff AE; Holmes KA; Ali HR; Dunning MJ; Brown GD; Gojis O; Ellis IO; Green AR; Ali S; Chin SF; Palmieri C; Caldas C; Carroll JS
    Nature; 2012 Jan; 481(7381):389-93. PubMed ID: 22217937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dominant-negative nuclear receptor corepressor relieves transcriptional inhibition of retinoic acid receptor but does not alter the agonist/antagonist activities of the tamoxifen-bound estrogen receptor.
    Morrison AJ; Herrera RE; Heinsohn EC; Schiff R; Osborne CK
    Mol Endocrinol; 2003 Aug; 17(8):1543-54. PubMed ID: 12730327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A CTCF-independent role for cohesin in tissue-specific transcription.
    Schmidt D; Schwalie PC; Ross-Innes CS; Hurtado A; Brown GD; Carroll JS; Flicek P; Odom DT
    Genome Res; 2010 May; 20(5):578-88. PubMed ID: 20219941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent mutations at estrogen receptor binding sites alter chromatin topology and distal gene expression in breast cancer.
    Yang J; Wei X; Tufan T; Kuscu C; Unlu H; Farooq S; Demirtas E; Paschal BM; Adli M
    Genome Biol; 2018 Nov; 19(1):190. PubMed ID: 30404658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.
    Fleming FJ; Hill AD; McDermott EW; O'Higgins NJ; Young LS
    J Clin Endocrinol Metab; 2004 Jan; 89(1):375-83. PubMed ID: 14715875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF).
    Klinge CM
    J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):1-19. PubMed ID: 10619353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scaffold attachment factor SAFB1 suppresses estrogen receptor alpha-mediated transcription in part via interaction with nuclear receptor corepressor.
    Jiang S; Meyer R; Kang K; Osborne CK; Wong J; Oesterreich S
    Mol Endocrinol; 2006 Feb; 20(2):311-20. PubMed ID: 16195251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation of mixed lineage kinase 3 by estrogen and its implication in ER-positive breast cancer pathogenesis.
    Viswakarma N; Nair RS; Sondarva G; Das S; Ibrahimi L; Chen Z; Sinha S; Rana B; Rana A
    Oncotarget; 2017 May; 8(20):33172-33184. PubMed ID: 28388540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-specific mutation of GATA3 disrupts the transcriptional regulatory network governed by Estrogen Receptor alpha, FOXA1 and GATA3.
    Takaku M; Grimm SA; De Kumar B; Bennett BD; Wade PA
    Nucleic Acids Res; 2020 May; 48(9):4756-4768. PubMed ID: 32232341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic estrogen receptor interactomes control estrogen-responsive trefoil Factor (TFF) locus cell-specific activities.
    Quintin J; Le Péron C; Palierne G; Bizot M; Cunha S; Sérandour AA; Avner S; Henry C; Percevault F; Belaud-Rotureau MA; Huet S; Watrin E; Eeckhoute J; Legagneux V; Salbert G; Métivier R
    Mol Cell Biol; 2014 Jul; 34(13):2418-36. PubMed ID: 24752895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The BET Protein BRD2 Cooperates with CTCF to Enforce Transcriptional and Architectural Boundaries.
    Hsu SC; Gilgenast TG; Bartman CR; Edwards CR; Stonestrom AJ; Huang P; Emerson DJ; Evans P; Werner MT; Keller CA; Giardine B; Hardison RC; Raj A; Phillips-Cremins JE; Blobel GA
    Mol Cell; 2017 Apr; 66(1):102-116.e7. PubMed ID: 28388437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mechanism for CTCF in the epigenetic regulation of Bax in breast cancer cells.
    Méndez-Catalá CF; Gretton S; Vostrov A; Pugacheva E; Farrar D; Ito Y; Docquier F; Kita GX; Murrell A; Lobanenkov V; Klenova E
    Neoplasia; 2013 Aug; 15(8):898-912. PubMed ID: 23908591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
    Katzenellenbogen BS; Montano MM; Ediger TR; Sun J; Ekena K; Lazennec G; Martini PG; McInerney EM; Delage-Mourroux R; Weis K; Katzenellenbogen JA
    Recent Prog Horm Res; 2000; 55():163-93; discussion 194-5. PubMed ID: 11036937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.